Clinical report of intravitreal Bevacizumab for 26 cases with retinopathy of prematurity in Zone Ⅰ

Clinical report of intravitreal Bevacizumab for 26 cases with retinopathy of prematurity in Zone Ⅰ

AIM:To investigate the clinical effects of intravitreal Bevacizumab for 26 cases with retinopathy of prematurity(ROP)in Zone Ⅰ. <p>METHODS:A retrospective study. Totally 26 ROP infants between September 2013 and October 2014 diagnosed as high-risk ROP in Zone Ⅰ had been treated with intravitre...

Full description

Bibliographic Details
Main Authors:	Feng Chen, Dao-Man Xiang, Jian-Xun Wang, Tian Liu
Format:	Article
Language:	English
Published:	Press of International Journal of Ophthalmology (IJO PRESS) 2016-07-01
Series:	Guoji Yanke Zazhi
Subjects:	threshold retinopathy of prematurity pre-threshold retinopathy of prematurity acute posterior retinopathy of prematurity intravitreal injection bevacizumab
Online Access:	http://ies.ijo.cn/cn_publish/2016/7/201607042.pdf

Similar Items

Intravitreal bevacizumab (Avastin) for post laser anterior segment ischemia in aggressive posterior retinopathy of prematurity
by: Shah Parag, et al.
Published: (2007-01-01)

Reactivation of retinopathy of prematurity after intravitreal bevacizumab monotherapy in aggressive posterior retinopathy of prematurity
by: Ritesh Verma, et al.
Published: (2023-01-01)

Comparison of aflibercept and bevacizumab in the treatment of type 1 retinopathy of prematurity
by: Hamid Riazi-esfahani, et al.
Published: (2021-10-01)

Bevacizumab treatment reduces retinal neovascularization in a mouse model of retinopathy of prematurity
by: Fei Feng, et al.
Published: (2014-08-01)

Ten-year outcomes after initial management with laser photocoagulation versus intravitreal bevacizumab injection in a pair of identical twins with aggressive posterior retinopathy of prematurity
by: Seung Hee Jeon, et al.
Published: (2021-06-01)

Pharmacological Approach for Treatment of Retinopathy of Prematurity
by: İmren Akkoyun
Published: (2012-12-01)

Effect of two different doses of intravitreal bevacizumab with temporal retina-sparing laser photocoagulation for retinopathy of prematurity
by: A Young Choi, et al.
Published: (2018-01-01)

Intravitreal Ranibizumab for Aggressive Posterior Retinopathy of Prematurity
by: Xiu-Juan Li, et al.
Published: (2016-01-01)

Ocular and Systemic Results of Intravitreal Bevacizumab Injection in Retinopathy of Prematurity Treatment
by: Sadik Gorkem Cevik, et al.
Published: (2020-08-01)

Usefulness of Intravitreal Bevacizumab for Retinopathy of Prematurity with Severely Dilated Tunica Vasculosa Lentis and Poor Mydriasis
by: Tomoaki Higashiyama, et al.
Published: (2017-03-01)

Intravitreal ranibizumab injections in patients with retinopathy of prematurity (ROP)
by: Zuluaga Gómez, Liliana María, et al.
Published: (2018-01-01)

Efficacy of intravitreal bevacizumab for the treatment of Zone I Type 1 retinopathy of prematurity
by: Reza Karkhaneh, et al.
Published: (2018-01-01)

Efficacy evaluation of intravitreal ranibizumab therapy for three types of retinopathy of prematurity
by: Qiong Zou, et al.
Published: (2022-05-01)

Growth and neurodevelopmental status in patients with retinopathy of prematurity treated with intravitreal bevacizumab: a case–control study
by: Majid Abrishami, et al.
Published: (2021-11-01)

Intravitreal bevacizumab as rescue therapy following treatment failure with laser photocoagulation in retinopathy of prematurity
by: Caner Kara, et al.
Published: (2018-03-01)

The retinal vascular growth rate in babies with retinopathy of prematurity could indicate treatment need
by: Tapas Ranjan Padhi, et al.
Published: (2022-01-01)

Effect of intravitreal injection of bevacizumab-chitosan nanoparticles on retina of diabetic rats
by: Yan Lu, et al.
Published: (2014-02-01)

Anatomical outcome of laser treatment alone in aggressive retinopathy of prematurity
by: Anamika Dwivedi, et al.
Published: (2024-01-01)

Axial length, refraction, and retinal vascularization 1 year after ranibizumab or bevacizumab treatment for retinopathy of prematurity
by: Lin CJ, et al.
Published: (2016-07-01)

Efficacy of an Indian Bevacizumab BIOSimilar (BEVATAS) for Type 1 and Aggressive Posterior Retinopathy of Prematurity (BIOS-ROP Study)
by: Chakraborty S, et al.
Published: (2024-01-01)

Real-world scenario of retinopathy of prematurity in Kerala
by: Anubhav Goyal, et al.
Published: (2017-01-01)

The efficacy of intravitreal antivascular endothelial growth factor as primary treatment of retinopathy of prematurity: Experience from a tertiary hospital
by: H Kana, et al.
Published: (2017-03-01)

Experimental histopathological study on retinal and renal cellular response to intravitreous antiangiogenic drugs
by: João Borges Fortes Filho, et al.
Published: (2014-06-01)

The efficacy and ocular safety following aflibercept, conbercept, ranibizumab, bevacizumab, and laser for retinopathy of prematurity: a systematic review and meta-analysis
by: Jing Chen, et al.
Published: (2023-10-01)

Foveal and Retinal Nerve Fiber Layer Thickness in Children With a History of Retinopathy of Prematurity Treated With Bevacizumab: A Cross-sectional Study
by: Amir Eftekhari Milani, et al.
Published: (2023-10-01)

Revascularization of immature retinas with retinopathy of prematurity using combination therapy of deferred laser treatment after a single intravitreal bevacizumab injection
by: Ju Seouk Lee, et al.
Published: (2023-03-01)

Relationship between refractive outcomes and quantitative retinal vascularization and severity of plus disease in eyes treated with intravitreal bevacizumab
by: Sadik Etka Bayramoglu, et al.
Published: (2022-01-01)

Intravitreal Injection of Bevacizumab for Retinopathy of Prematurity in an Infant with Peters Anomaly
by: Tsuyoshi Minami, et al.
Published: (2014-10-01)

The modern view on the concept of treatment of active stages of retinopathy of prematurity
by: A. V. Tereshchenko, et al.
Published: (2014-07-01)

TREATMENT OF ACTIVE STAGES OF RETINOPATHY OF PREMATURE BABIES WITH THE USE OF MODERN TECHNOLOGIES
by: A. V. Tereshchenko, et al.
Published: (2015-12-01)

Treatment of active stages of retinopathy of premature babies with the use of modern technologies
by: A.V. Tereshchenko, et al.
Published: (2013-02-01)

Intravitreal Bevacizumab (Avastin) in Treatment of Vitreous Hemorrhage due to Proliferative Diabetic Retinopathy
by: Attaullah Shah Bukhari, et al.
Published: (2018-06-01)

STAGES OF PROVIDING COMPREHENSIVE EYE CARE FOR PREMATURE CHILDREN WITH PREMATURE RETINOPATHY
by: A. V. Tereshchenko, et al.
Published: (2015-12-01)

Stages of providing comprehensive eye care for premature children with premature retinopathy
by: A.V. Tereshchenko, et al.
Published: (2013-01-01)

FLUORESCEIN ANGIOGRAPHY OPPORTUNITIES IN THE DIAGNOSIS AND TREATMENT TACTICS FOR RETINOPATHY OF PREMATURITY IN CASE OF ACTIVE STAGES
by: A. V. Tereshchenko, et al.
Published: (2015-10-01)

System of the ophthalmologic help premature children with retinopathy of prematurity in the Central region of Russia
by: A. V. Tereshchenko, et al.
Published: (2014-07-01)

Retinopathy of prematurity: preferred practice patterns among pediatric ophthalmologists
by: Fouzdar Jain S, et al.
Published: (2018-05-01)

Factors Associated with Retinopathy of Prematurity in Hospitalized Preterm Infants in Sanandaj, Iran
by: Majid Mansouri, et al.
Published: (2016-09-01)

Profile of asymmetrical retinopathy of prematurity in twins
by: Azad Rajvardhan, et al.
Published: (2010-01-01)

Intraocular pressure effect of intravitreal conbercept injection for retinopathy of prematurity
by: Caifeng Gao, et al.
Published: (2023-05-01)